IQVIA Holdings Inc. (IQV)
| Market Cap | 44.92B |
| Revenue (ttm) | 12.01B |
| Net Income (ttm) | 409.00M |
| Shares Out | 191.50M |
| EPS (ttm) | 2.10 |
| PE Ratio | 110.37 |
| Forward PE | 27.93 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $231.78 |
| Previous Close | $234.39 |
| Change ($) | -2.62 |
| Change (%) | -1.12% |
| Day's Open | 234.96 |
| Day's Range | 231.28 - 235.86 |
| Day's Volume | 566,179 |
| 52-Week Range | 128.52 - 237.47 |
IQVIA (IQV) could produce exceptional returns because of its solid growth attributes.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) announced today that it will collaborate with Corium, Inc – a commercial-stage biopharmaceutical company leading the development and comm...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Global spending on medicines — using invoice price levels — is expected to grow at 3-6 percent CAGR through 2025 to reach about $1.6 trillion by 2025, excl...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, tod...
IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IQVIA's (IQV) first-quarter 2021 earnings and revenues increase year over year.
IQVIA (IQV) delivered earnings and revenue surprises of 17.84% and 7.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA revenue for the first quarter of $3,409 million increased 23.8 percent on a reported basis and 21.4 percent at constant currency
IQVIA's (IQV) first-quarter 2021 earnings and revenues are expected to have improved year over year.
IQVIA Holdings (IQV) has been benefiting from consecutive better-than-expected top- and bottom-line performances, and encouraging yearly EPS guidance.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQ...
IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.
SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research ser...
IQVIA Holdings (IQV) rises on consistent shareholder-friendly measures and strong healthcare-specific infrastructures. Meanwhile,the company's debt-laden balance sheet is a concern.
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) announced today that more than 60 trials spanning over 40 countries utilize its innovative decentralized clinical trial ...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janss...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will p...
IQVIA (IQV) has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities and a robust real-world solutions ecosystem.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering o...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced that 140 life science companies in nearly 90 countries have selected Orchestrated Customer Engagement (OC...
IQVIA's (IQV) fourth-quarter 2020 revenues and earnings increase year over year.
IQVIA (IQV) delivered earnings and revenue surprises of 4.98% and 4.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
IQVIA's (IQV) fourth-quarter 2020 earnings and revenues are expected to have improved year over year.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) today announced that it has been recognized as a top performer by survey respondents in Industry Standard Research's eC...
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine's “World's Most Admired Companies” list. IQVIA has received t...
IQVIA demonstrates a strong sequential growth pattern, in near recovery to pre-pandemic volumes. Management have reinstated the buyback program, with ~$1 billion in authorization, and look set on acquis...
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can b...
Over halfway through the trading day on Tuesday, and the broad markets have yet to make up their minds.
MORRISVILLE, N.C.--(BUSINESS WIRE)--Q2 Solutions, a leading global clinical trial laboratory services organization, resulting from an IQVIA and Quest Diagnostics joint venture, today announced a partner...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life scienc...
IQVIA Holdings (IQV) stock has been benefiting from consecutive better-than-expected top- and bottom-line performances and encouraging yearly guidance.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) said today that it is pleased to be a supporter of the Real World Evidence Leadership Forum, a group consisting of seni...
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
Consecutive better-than-expected top- and bottom-line performances, encouraging yearly guidance and shareholder friendly moves have been aiding IQVIA Holdings (IQV) stock.
IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q3 2020 Results - Earnings Call Transcript
IQVIA's (IQV) third-quarter 2020 revenues and earnings increase year over year.
IQVIA (IQV) delivered earnings and revenue surprises of 7.95% and 1.29%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of IQVIA Holdings (NYSE:IQV) rose 3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 1.87% over the past year to $1.63, which beat the estim...
IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
IQVIA's (IQV) third-quarter 2020 earnings and revenues are expected to have declined year over year.
IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA Holdings (IQV) stock has been benefiting from consecutive better-than-expected top- and bottom-line performances and encouraging yearly guidance.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV), in scientific partnership with the U.S. Food and Drug Administration, will provide agile analytics from IQVIA’s CARE P...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its third-quarter financial results before the market opens on Tuesday, October 2...
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.
About IQV
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and dissemin... [Read more...]
| Industry Diagnostics & Research | IPO Date May 9, 2013 |
| CEO Ari Bousbib | Employees 72,000 |
| Stock Exchange NYSE | Ticker Symbol IQV |
Financial Performance
In 2020, IQVIA Holdings's revenue was $11.36 billion, an increase of 2.44% compared to the previous year's $11.09 billion. Earnings were $279.00 million, an increase of 46.07%.
Analyst Forecasts
According to 21 analysts, the average rating for IQVIA Holdings stock is "Buy." The 12-month stock price forecast is 256.32, which is an increase of 10.59% from the latest price.